Darell D Bigner

USPTO Granted Patents = 55 (Patent Applications = 27)

CIPO Patents = 8

EPO Patents = 15 (Patent Applications = 22)

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 405(Granted Patents)

Forward Citations (Not Self Cited) = 385(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Chapel Hill, NC (US) (1993 - 1998)
Durham, NC (US) (2013 - 2020)
Mebane, NC (US) (1996 - 2023)

Company Filing History:

Johns Hopkins University

patents

10 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

4. 2 out of 1,521

Cornell Research Foundation Inc.

patents

5. 1 out of 260

St. Jude Children's Research Hospital

patents

6. 1 out of 8,684

US Government As Represented by the Secretary of the Army

patents

7. 1 out of 5,450

The University of Texas System

patents

8. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2023

Loading Chart...

Areas of Expertise:

Oncolytic Poliovirus

Immunotherapy

Tumor Response Prediction

Antigen Presenting Cells

Immunotoxin Therapy

Genetic Alterations

Bispecific Antibodies

Checkpoint Inhibitors

Oligodendroglioma

EGFRvIII Antibodies

Somatic Mutations

Cellular Vaccines

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11813298 - Oncolytic poliovirus for human tumors (2023-11-14),

2. 11506666 - Detection of CD-155, the poliovirus receptor (2022-11-22),

3. 11428691 - Methods for predicting tumor response to immunotherapy (2022-08-30),

4. 11406677 - Oncolytic poliovirus for human tumors (2022-08-09),

5. 11331343 - Compositions and methods for activating antigen presenting cells with chimeric poliovirus (2022-05-17),

6. 11311628 - Production of immunotoxin D2C7—(scdsFv)—PE38KDEL (2022-04-26),

7. 11306364 - promoter mutations in gliomas and a subset of tumors (2022-04-19),

8. 11254988 - Somatic mutations in ATRX in brain cancer (2022-02-22),

9. 11065332 - Combination therapy of immunotoxin and checkpoint inhibitor (2021-07-20),

10. 10894987 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2021-01-19),

11. 10837064 - Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma (2020-11-17),

12. 10799543 - Oncolytic poliovirus for human tumors (2020-10-13),

13. 10744171 - Sequential anti-cancer treatment (2020-08-18),

14. 10744170 - Combination treatment (2020-08-18),

15. 10711310 - Tert promoter mutations in gliomas and a subset of tumors (2020-07-14),

Title: Darell D Bigner - Pioneering Inventor from Mebane, NC

Introduction: Darell D Bigner is a renowned inventor hailing from Mebane, North Carolina. He has made significant contributions to the field of innovation and holds numerous patents in his name.

Latest Patents: Darell D Bigner's latest patents focus on advancements in medical technology, particularly in the areas of cancer research and treatment. His innovative solutions have the potential to revolutionize the way we approach healthcare.

Career Highlights: With a distinguished career spanning several decades, Darell D Bigner has established himself as a leading figure in the world of inventors. His work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout his career, Darell D Bigner has collaborated with top researchers, scientists, and medical professionals to bring his inventions to life. His ability to work in multidisciplinary teams has led to groundbreaking discoveries in the field.

Conclusion: Darell D Bigner's passion for innovation and commitment to improving lives through his inventions make him a true pioneer in the world of inventors. His legacy continues to inspire future generations to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.